Corvus Pharmaceuticals, Inc. — Director's Dealing 2018

Jan 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2018-01-19

Reporting Person: Buggy Joseph J (EVP Discovery Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-19	Stock Option (Right to Buy)	$9.94	A	100000	Acquired	2028-01-19	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value	84876	Direct
Common Stock, $0.0001 par value	266310	Indirect

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: These shares are held by Buggy / Cooper Living Trust dated June 25, 2014, Joseph J. Buggy / Anne Cooper Trustees (the "Buggy Trust"). Dr. Buggy has shared voting, investment and dispositive power over the shares held by the Buggy Trust.

F3: The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from January 19, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.